BKHA

Black Hawk Acquisition Corp

Nasdaq· Biological Products, (No Diagnostic Substances)· CIK 0002000775 Biotech & Drug Discovery

$5.04 −0.36 (−6.67%)

Oct 26 4:00 PM ET · prev $5.40

1 year

−56.0%

from $11.46 · Oct 27

30 days

−59.1%

from $12.31

52-week range

$4.03–13.10

−62% from high · low Oct 19

Avg volume 20D

49.1K

Oct 13 spike 205.2K

Short interest

501

+845.3%

Days to cover

1.0

at average volume

Filing reports

analyzed by SecBot

SecBot read BEARISH 7 reports · 90 days

Balance 2 bearish · 0 bullish · 1 mixed · 4 neutral oldest → newest, height = score

Avg score

·High conf. 5/7

Strongest BEARISH Black Hawk Acquisition Corp filed a 424B4 prospectus/proxy statement for its Extraordinary General Meeting…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Jul 15 Short interest falls 32.9% to 49
X Aug 31 Short interest jumps 652.4% to 316
R Sep 4 Black Hawk Acquisition Corp filed Amendment No. 8 to its S-4 registr…
X Sep 15 Short interest falls 83.2% to 53
R Sep 22 Black Hawk Acquisition Corp filed a 424B4 prospectus/proxy statement…
R Sep 24 Black Hawk Acquisition Corp. (BKHA) entered into a comprehensive fin…
X Sep 30 Short interest jumps 845.3% to 501
E Oct 19 Trading halt: Halt Resumed: BKHA — trading resumed after LUDP (Volatilit…

Signal stack

Where each data set points today.

Short sellersBUILDING

Short interest +845.3% to 501 shares. 1.0 days to cover.
TrendDOWNTREND

54% below its 50-day average.

Who's buying

13F

Top holder	Shares	Value
WOLVERINE ASSET MANAGEMENT LLC	331,222	$3.9M
Clear Street Group Inc.	81,481	$970.4K
D. E. Shaw & Co., Inc.	75,000	$882.8K
Calamos Advisors LLC	24,591	$289.4K
GOLDMAN SACHS GROUP INC	10,635	$124.6K
BNP PARIBAS FINANCIAL MARKETS	4,572	$53.6K
UBS Group AG	184	$2.2K
MORGAN STANLEY	57	$668.00

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 26, 2026 Trading halt

🔒 Fresh data, subscribers only

Oct 23, 2026 SEC

Black Hawk Acquisition Corp deposited $150,000 into its trust account to extend the deadline for completing an initial…

8-K — Impact 2/10

Oct 7, 2026 SEC

Wolverine Asset Management LLC filed an amended Schedule 13G disclosing a 5.09% passive stake in Black Hawk…

SC 13G/A — Impact 3/10

Sep 24, 2026 SEC

Black Hawk Acquisition Corp. (BKHA) entered into a comprehensive financing package with Meteora Select Trading…

8-K — Impact 6/10

Earnings setup

Estimates

Period	EPS est.	Range	30D rev.	Revenue
Current Q	—	—	—	$0.00
Next Q	—	—	—	$0.00
Current FY	—	—	—	$0.00
Next FY	—	—	—	$0.00

Short side

FINRA· Sep 30, 2026

501

shares short

+845.3%

vs prior settlement

1.0

days to cover

Trading halts

Oct 26, 2026	🔒 Fresh data, subscribers only
Oct 19, 2026	Volatility Pause	Resumed
Oct 19, 2026	Volatility Pause	Resumed
Oct 16, 2026	Volatility Pause	Resumed
Oct 14, 2026	Volatility Pause	Resumed